alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### TEXA S C OU R T OF A PPEAL S, THIR D DIST R ICT , AT AU STIN NO. 03-06-00103- CV M ar ia S or e nse n, A ppe lla nt

v. CitiBank(South Dakota), N.A., Appellee F ROM THE COUNTY COURT AT LAW NO. 2 OF WILLI AMSO N COUNTY NO. 04-1 222 00 2, HO NORAB LE TIMO THY L. WRIGHT, JUDGE P RESIDING

ME MO R

A ND UMO P I N I O N The trial c ourt signe d its final judgme nt on Dece mber 27, 2005. On January 30, a pp e lla nt f ile d h e r n oti c e of a

pp e a l, and on F e br

ua ry 13 , sh e fi le d a

mot ion fo r a n e xten sio n o f t ime to file her n o t i ce of appe al. We g rante d her motion for a n extension of tim e on Mar ch 14. The rec ord wa s due on F ebrua ry 27. On Marc h 14, we se nt notice that the reporter’ s rec ord wa s overdue . On Marc h 20, the cour

t reporte r re sponded with a letter informing this Court that the parties ha d not reque sted a reporter’ s rec ord. On Mar ch 29, we sent n o tice that ar rang ements had not be en made for the c lerk’s r ecor d to be filed, re questingthat appellant r espond with a status re port no later tha n April 10, and on April 24, appellant notified this Court that she had paid for the c lerk’s r ecor d. The cler k’s re cord w as filed on Ma y 4, and on June 21, we sent appel l an t n o t ice that he r brief was ov e rd ue . We inf

or me d ap pe lla

nt that unle ss she fi le d a pro pe r mot ion by July 3, he r a pp e a l w ou ld2

be dis mis se d. To date , a

pp e lla nt ha s n ot r e sp on de d to thi s Co ur t’ s n oti c e s. We t

he re fo re dis mis s the appe al for w ant of prose cution on our own motion. Tex. R . App. P. 42.3(b).

__________________________________________ David Puryear , J ustice Be fore J ustices B . A. Smith, P uryear , and Waldrop Dismissed for Want of Prosecution Filed: August 9, 2006
EXHIBIT 4.1

 Number                                                      Shares

        Incorporated under the Laws of the State of Delaware

                     SUNDEW INTERNATIONAL, INC.

               Authorized to issue 120,000,000 shares

     100,000,000 common shares      20,000,000 preferred shares
     par value $.001 each           par value $.001 each


This certifies that _______________________________________ is the
owner of ___________________________________ fully paid and
non-assessable Shares of the Common Shares of Sundew International,
Inc. transferrable only on the books of the Corporation by the
holder hereof in person or by duly authorized Attorney upon
surrender of this Certificate properly endorsed.

      IN WITNESS WHEREOF, the said Corporation has caused this
Certificate to be signed by its duly authorized officers and to be
sealed with the Seal of the Corporation

                      this ________ day of ____________ A.D. _____


                           _______________________________________
                                                         President

                              [SEAL]

                (Reverse side of stock certificate)

      The following abbreviations, when used in the inscription on
the face of this certificate, shall be construed as though they were
written out in full according to applicable laws or regulations.
Additional abbreviations may also be used though not in the list.

TEN COM -- as tenants in common
TEN ENT -- as tenants by the entireties
JT TEN  -- as joint tenants with right of survivorship
           and not as tenants in common

UNIF GIFT MIN ACT -- ____________ Custodian _________ (Minor) under
Uniform Gifts to Minors Act ______________ (State)

      For value received, the undersigned hereby sells, assigns and
transfers unto ______________________________________ (please insert
social security or other identifying number of assignee)
______________________________________________



_______________________________________________________________________
       (please print or typewrite name and address of assignee)

________________________________ Shares represented by the within
Certificate, and hereby irrevocably constitutes and appoints
____________________  Attorney to transfer the said shares on the
books of the within-named Corporation with full power of
substitution in the premises.

Dated, _______________________________

       In presence of
_______________________________

_______________________________

NOTICE: The signature to this assignment must correspond with the
name as written upon the face of the certificate in every particular
without alteration or enlargement, or any change whatever.
[Federal Register Volume 73, Number 10 (Tuesday, January 15, 2008)]
[Notices]
[Page 2513]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-97]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Training Grant and Career Development Review 
Committee.
    Date: February 4-5, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Fairmont Washington, DC, 2401 M Street, NW., 
Washington, DC 20037.
    Contact Person: Raul A. Saavedra, PhD., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS, NSC; 6001 Executive Blvd., STE. 3208, Bethesda, MD 
20892-9529, 301-496-9223, <a href="/cdn-cgi/l/email-protection#156674746370716767557b7c7b71663b7b7c7d3b727a63"><span class="__cf_email__" data-cfemail="413220203724253333012f282f25326f2f28296f262e37">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: January 8, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-97 Filed 1-14-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 4.11

 


	
Number
   B-
    	
 
    	
Incorporated Under the Laws of the State of Delaware
    	
 
    	
Shares
   -0-
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
Cusip No.
    




 

LIBERTY MEDIA CORPORATION

 

Series B Liberty Media Common Stock, par value $.01 per share

 

Specimen Certificate

 

This Certifies that [               ] is the owner of [               ] FULLY PAID AND NON-ASSESSABLE SHARES OF SERIES B LIBERTY MEDIA COMMON STOCK, PAR VALUE $0.01 PER SHARE, OF LIBERTY MEDIA CORPORATION (hereinafter called the “Corporation”) transferable on the books of the Corporation by the holder hereof in person or by duly authorized attorney upon surrender of the Certificate properly endorsed. This Certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar.

 

Witness, the seal of the Corporation and the signatures of its duly authorized officers.

 

Dated:

 

Liberty Media Corporation

 

[Corporate Seal]

 

	
 
    	
 
    	
 
    
	
President
    	
 
    	
Secretary
<PAGE>
 
                                 VISTANA, INC.
                           8801 VISTANA CENTRE DRIVE
                            ORLANDO, FLORIDA  32821

                                 March 4, 1999



Mr. Raymond L. Gellein, Jr.
Chairman 
Vistana, Inc.

     Re:  Second Amendment to Employment Agreement
          ----------------------------------------

Dear Rip:

     Attached hereto is a revised Schedule B to the Employment Agreement dated
December 27, 1996 and amended as of May 28, 1998 between Vistana, Inc. and you
which incorporates the adjustment to your Base Salary and Annual Bonus Amount
for the 1999 fiscal year approved by the Compensation Committee at its February
meeting.

     Please carefully review the enclosed Schedule B to confirm the accuracy
thereof. If the enclosed Schedule B is accurate, please execute the enclosed
copy of this letter in the space provided below and return it to the
undersigned, whereupon the enclosed Schedule B will be substituted for the
existing Schedule B. Please keep your copy of this letter and revised Schedule B
with your own copy of your Employment Agreement.

                                   Very truly yours,             
                                                                
                                   VISTANA, INC.                
                                                                
                                       /s/ Jeffrey A. Adler
                                   By:_________________________ 
                                         Name: Jeffrey A. Adler           
                                         Title: President        

Enclosure

ACKNOWLEDGED AND CONFIRMED:

/s/ Raymond L. Gellein, Jr.
_________________________________
Name: Raymond L. Gellein, Jr.
<PAGE>
 
                                   SCHEDULE B
                                   ----------
                                        
                             EMPLOYEE COMPENSATION
                             ---------------------
                      (Revised Effective January 1, 1999)
 
1.   Employee Name:              Raymond L. Gellein, Jr.
     -------------
 
2.   Base Salary:                $430,000
     -----------
 
3.   Annual Bonus Amount:        Up to 100% of Adjusted Base Salary; Formula to
     -------------------
                                 approximate that of other senior executive
                                 officers.
                                 
4.   Severance Amount:           [Intentionally Omitted]
     ----------------
 
5.   Monthly Severance Payment:  [Intentionally Omitted]
     -------------------------
Exhibit 99.2

                         CERTIFICATION PURSUANT TO
                          18 U.S.C. SECTION 1350,
                          AS ADOPTED PURSUANT TO
               SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Annual Report of New Jersey Mining Company
(the "Company") on Form 10-KSB for the period ended December 31, 2002, as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Grant A. Brackebusch, Vice President of the Company, certify to
the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant
to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

    (1)  The Report fully complies with the requirements of Section 13(a) or
     15(d) of the Securities Exchange Act of 1934; and

    (2)  The information contained in the Report fairly presents, in all
     material respects, the financial condition and result of operations
     of the Company.


/s/Grant A. Brackebusch
-------------------
Grant A. Brackebusch
Vice President
March 25, 2003
EXHIBIT 32.1
  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO SECTION 906
 OF THE SARBANES-OXLEY ACT OF 2002
  The undersigned, Dongliang Chen, the Chief Executive Officer of CHINA POLYPEPTIDE GROUP, INC. (the “Company”), DOES HEREBY CERTIFY that:
  1. The Company’s Quarterly Report on Form 10-Q for the six months ended March 31, 2009 (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
  2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
  IN WITNESS WHEREOF, the undersigned has executed this statement this 16th day of May, 2011.
  /s/ Dongliang ChenDongliang ChenChief Executive Officer(Principal Executive Officer)
  A signed original of this written statement required by Section 906 has been provided to China Polypeptide Group, Inc. and will be retained by China Polypeptide Group, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
  The forgoing certification is being furnished to the Securities and Exchange Commission pursuant to Sec. 18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service 

 National Institute for Occupational 

 Safety and Health 

Robert A. Taft Laboratories

 4676 Columbia Parkway 

Cincinnati, OH 45226-1998 

Phone: 513-533-6825 

Fax: 513-533-6826 

February 24, 2009 

SEC Tracking Number: SEC00134 

Ms. Rachel Leiton 

Division of Energy Employees Occupational 

 Illness Compensation 

U.S. Department of Labor 

Room C-4511 

200 Constitution Avenue, N.W. 

Washington, D.C. 20210 

Dear Ms. Leiton: 

On behalf of the Secretary of the Department of Health and Human Services (HHS), and as 

required by 42 C.F.R. § 83.17(c), I am notifying you of the final effect of the HHS decision to 

designate a class of employees at Vitro Manufacturing in Canonsburg, Pennsylvania, as an addition 

to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness 

Compensation Program Act of 2000. On January 16, 2009, as provided for under 42 U.S.C. § 

7384q(b), the Secretary of HHS designated the following class of employees as an addition to the 

SEC: 

All AWE employees who worked at Vitro Manufacturing in Canonsburg, Pennsylvania, from 

August 13, 1942 through December 31, 1957, for a number of work days aggregating at 

least 250 work days, occurring either solely under this employment or in combination with 

work days within the parameters established for one or more other classes of employees in 

the Special Exposure Cohort. 

This designation became effective on February 15, 2009, as provided for under 42 U.S.C. § 

7384l(14)(C). Hence, beginning on February 15, 2009, members of this class of employees, 

defined as reported in this notice, became members of the SEC. 

 Sincerely, 

Larry J. Elliott 

 Director 

 Office of Compensation Analysis and Support 

 National Institute for Occupational Safety and Health
**Exhibit
      32.2**




CERTIFICATION
      PURSUANT TO


18
      U.S.C. SECTION
      1350,


AS
      ADOPTED PURSUANT
      TO


SECTION
      906 OF THE
      SARBANES-OXLEY ACT OF 2002




In
      connection with
      the report of Med-Emerg International Inc. (the "Company") on Form 10-K for
      the
      period ended December 31, 20065 as filed with the Securities and Exchange
      Commission on the date hereof (the "Report"), I, William Danis Chief Financial
      Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted
      pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my
      knowledge:




1)  The
      Report fully
      complies with the requirements of section 13(a) or 15(d) of the Securities
      Exchange Act of 1934; and




2)  The
      information
      contained in the Report fairly presents, in all material respects, the financial
      condition and result of operations of the Company.




Dated:
      April 17,
      2007




By:
                /s/
                William DanisName:
                William
                DanisTitle:
                Chief
                Financial Officer
Texas State Board of Pharmacy

Gunter Hotel San Antonio, Texas Gentlemen: ATTRRTIOR: W. Ii.Coualns Opinion Ro. O-3109 Re: Whether Pharmacy' Board may confiscate certificatefrom foreign state oft

pharmacist not registered In Texas. This will acknowledge receipt of your letter of January 30, 1941, requesting the opinion of this department upon the followingmatter:

"Does the Texas State Board of Pharmacy have the power or right to confiscateany certificateheld by a person not registered as a pharmacist'lnTexas, but who is registeredby some other state, and who is usinghis certlficate issuedby that state topracticepharmacy In Texas, displaying and exhibiting sameas a subterfugeto the public?"
We have carefully examined the provisions of Chapter 8 of Title 71 of theRevised Civil Statutes relating to the practice of pharmacy In this State and the powers and duties of the State Board of Pharmacy;yet, we have been unable to discover that the Legislaturehas authorized the Board or Its agents to confiscatea certificate to practice pharmacy issued by a foreign state and used by a pharmacist inTexas as a subterfuge to practice pharmacy In this State without registration.

Of course,as we pointed out in OpinionNo. O-2321, if a pharmacist registered in another statepractices in this statewithout license from the State Board of Pharmacy, or does not operate under the direct supervisionof one so registered,he will be committinga misdemeanor in violation of Article 758a of Vernon's Annotated Penal Code.Texas State Board of Pharmacy, Page 2

However, It is the opinion of this Department and you are advised that the State Board of Pharmacy has no power or authority to confiscatea certificate to practice pharmacy Issuedby another stateused as a subterfugeby a pharmacist to practice in this State without registration.
Yours very truly,

JDS:JS:hep

APPROVED FEB 4, 1941 Gerald C. Mann ATTORNEY GENERAL OF TEXAS
APPROVED OPINION COMMITTEE BY BWB CHAIRMAN By a/ James D. Smullen James D. Smullen

Assistant
II

106TH CONGRESS

1ST SESSION S. 1541

To amend the Employee Retirement Income Security Act of 1974 to require

annual informational statements by plans with qualified cash or deferred

arrangements, and for other purposes.

IN THE SENATE OF THE UNITED STATES

AUGUST 5, 1999

Mr. JOHNSON introduced the following bill; which was read twice and referred

to the Committee on Health, Education, Labor, and Pensions

A BILL

To amend the Employee Retirement Income Security Act

of 1974 to require annual informational statements by

plans with qualified cash or deferred arrangements, and

for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘401(k) Full Disclosure

5 Act’’.
2

•S 1541 IS

1 SEC. 2. ANNUAL INFORMATIONAL STATEMENTS BY 401(k)

2 PLANS.

3 (a) IN GENERAL.—Section 104(b)(3) of the Em4 ployee Retirement Income Security Act of 1974 (29

5 U.S.C. 1024(b)(3)) is amended—

6 (1) by inserting ‘‘(A)’’ after ‘‘(3)’’; and

7 (2) by adding at the end the following new sub8 paragraph:

9 ‘‘(B) If a plan includes a qualified cash or de10 ferred arrangement (as defined in section 401(k)(2)

11 of the Internal Revenue Code of 1986), the adminis12 trator shall furnish to each participant, or alternate

13 payee under any qualified domestic relations order,

14 receiving benefits under the plan a statement no less

15 frequently than annually providing—

16 ‘‘(i) the individual’s account balance as of

17 the beginning and ending of the statement pe18 riod;

19 ‘‘(ii) the investment performance of each

20 investment option for the statement period;

21 ‘‘(iii) the total assets of the plan;

22 ‘‘(iv) the administrative fees of the plan for

23 the statement period as a percentage of the

24 total assets of the plan;

25 ‘‘(v) the name of the plan administrator.’’.
3

•S 1541 IS

1 (b) EFFECTIVE DATE.—The amendments made by

2 subsection (a) shall apply to plan years beginning after

3 the date of enactment of this Act.

Æ
CONSENT OF INDEPENDENT AUDITORS'

We hereby consent to the incorporation by reference in the Registration
Statement No. 333-31536 of Monarch Services, Inc. on Form S-8 of our
report dated June 23, 2000, appearing in the Annual Report on Form
10-KSB of Monarch Services, Inc. for the year ended April 30, 2000.

Stegman & Company
Baltimore, Maryland

July 28, 2000
EXHIBIT 32.1

      CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Lester G. Manalo, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge,
the amended Quarterly Report on Form 10-Q/A of Adtomize Inc. for the fiscal
quarter ended December 31, 2008 fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934 and that information
contained in such amended Quarterly Report on Form 10-Q/A fairly presents in all
material respects the financial condition and results of operations of Adtomize
Inc.


Date March 25, 2009                   By: /s/ Lester G. Manalo
                                          --------------------------------------
                                          Lester G. Manalo, President, Treasurer
                                          and Director Principal Executive and
                                          Financial Officer

This certification accompanies the Quarterly Report on Form 10-Q/A pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed for
purposes of Section 18 of the Exchange Act, or otherwise subject to the
liability of that section. This certification shall not be deemed to be
incorporated by reference into any filing under the Securities Act or the
Exchange Act, except to the extent that Adtomize Inc. specifically incorporates
it by reference.
Exhibit 31.4

NANOGEN, INC.

CERTIFICATIONS REQUIRED BY

RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

I, Nicholas J. Venuto, certify that:



|1. | I have reviewed this annual report on Form 10-K/A of Nanogen, Inc.;
|-- | -------------------------------------------------------------------



|2. | Based on my knowledge, this report on Form 10-K/A does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|-- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

April 29, 2008



/s/    NICHOLAS J. VENUTONicholas J. Venuto Chief Financial Officer (Principal Financial and Accounting Officer)